1st Quarter - Report

MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY for MCKESSON CORPORATION & ITS AFFILIATE U.S. ONCOLOGY

Firm
Client
Income
—
Expenses
$520,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Incentives for health information technology, Affordable Care Act implementation and other healthcare policy issues. Proposed regulation of medical software. Food and Drug Administration Safety and Innovation ActH.R. 2746, the Cancer Drug Coverage Parity Act. S. 752, the Lung Cancer Mortality Reduction Act.

LobbyistCovered position, as disclosed
ANN RICHARDSON BERKEY —
MATT BROW —
KEAGAN R LENIHAN —
GEOFF WERTH —

Contacted: Federal Communications Commission (FCC); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Bills named: S. 752 (113th)

Medicare/Medicaid MMM

Physician and pharmacy reimbursement issues. Implementation of the Affordable Care Act. H.R. 800, a bill to remove the prompt pay discount between the manufacturer and the distributor from the providers Medicare Part B drug reimbursement.H.R. 905/S.733, to amend Part B of title XVIII of the Social Security Act.

LobbyistCovered position, as disclosed
ANN RICHARDSON BERKEY —
MATT BROW —
KEAGAN R LENIHAN —
GEOFF WERTH —

Contacted: SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Federal Communications Commission (FCC); HOUSE OF REPRESENTATIVES

Bills named: S. 733 (113th), H.R. 800 (113th), H.R. 905 (113th)

Veterans VET

Existing Department of Veterans' Affairs Pharmaceutical Prime Vendor Contract.

LobbyistCovered position, as disclosed
ANN RICHARDSON BERKEY —

Contacted: Health & Human Services, Dept of (HHS); SENATE; Federal Communications Commission (FCC); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Implementation of the new medical device tax. Proposals to repeal LIFO.

LobbyistCovered position, as disclosed
ANN RICHARDSON BERKEY —

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; Federal Communications Commission (FCC)

Pharmacy PHA

Pharmacy issues Prescription drug supply chain issues, including security of the supply chain, drug shortages, prescription drug abuse and diversion.

LobbyistCovered position, as disclosed
ANN RICHARDSON BERKEY —

Contacted: Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE; Federal Communications Commission (FCC); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.